Brent crude oil jumped the most in history in the previous session after attacks on Saudi's oil industry disrupted the kingdom's production.Marketsread more
Damage to the top OPEC producer's oil facilities ignited fears of supply disruption around the world and has sent crude prices soaring.Energyread more
The second-largest investor in Kraft Heinz Company discloses that it has again trimmed its stake in the food company.Marketsread more
Elliott Management may not see John Stankey as a future leader at AT&T, but bailing on him before he executes his integration plan has the potential for disaster.Technologyread more
Tension between the real estate start-up WeWork and SoftBank was not a central issue in the decision to delay an initial public offering, sources tell CNBC's David FaberThe Faber Reportread more
The service will debut in April with pricing to be announced closer to the launch data, NBCUniversal says.Technologyread more
A sharp drop in mortgage rates in August was clearly behind the confidence in September. The survey came with warning signs, however. Mortgage rates shot back up at the start...Real Estateread more
U.S. manufacturing output increased more than expected in August, boosted by a surge in machinery and primary metals production.Economyread more
The risk of a global recession is at its highest since August 2009, according to a survey of fund managers.Marketsread more
Chipotle rewards members will get the first chance to order carne asada.Restaurantsread more
Apple isn't trying to blow our minds with groundbreaking new features on the iPhone 11, but is making lots of little improvements each year, this year focusing on cameras and...Technologyread more
* FTSE 100 down 0.3%, FTSE 250 up 0.2%
* Healthcare stocks hit after U.S. drops rebate rule
* Fed Chair's comments earlier reinforced rate cut bets
* Housebuilders shine after upbeat survey data
* Drugmaker Indivior surges after forecast upgrade (Adds news items, updates to closing prices)
July 11 (Reuters) - London's main index skidded for the sixth straight session on Thursday as investors sold off healthcare stocks after Washington withdrew a rebate rule aimed at lowering drug prices, and a Fed-fuelled rally fizzled out.
The FTSE 100 shed 0.3%, while the mid-cap FTSE 250 capitalised on a rise in sterling to add 0.1%.
The U.S. government scrapped one of its most ambitious proposals for lowering prescription medicine prices, backing down from a policy that would have required health insurers to pass on billions of dollars in rebates they receive from drugmakers to Medicare patients.
"Overall, we view this outcome as a modest negative for the major pharmaceutical group," JP Morgan analysts wrote, adding that the move had removed a "potential positive catalyst" for the sector.
Pharmaceutical heavyweight AstraZeneca was by far the biggest drag on the blue-chip index, while peer GlaxoSmithKline also fell.
The Trump administration's move wiped out gains the market had posted earlier, as it cheered dovish comments from the U.S. central bank that reinforced bets of an interest rate cut and lifted broader sentiment.
Losses were stemmed by shares of homebuilders, which enjoyed their best day in nearly a month after a survey revealed the housing market had shown tentative signs of recovery in June.
Barratt, Britain's biggest housebuilder, surged 5.2% on its best day in more than eight months.
Reckitt Benckiser added 2.4% after it agreed to pay up to $1.4 billion to resolve all U.S. federal investigations in connection with the sales and marketing of Suboxone Film by its former unit Indivior.
"With this settlement, management draws a line under an issue that would, at best, have resulted in additional cost/distraction/uncertainty and could, at worst, have led to much more costly and protracted legal proceedings," Deutsche Bank analysts said.
Indivior soared as much as 41% after it raised its annual profit and revenue forecast in a separate statement as Suboxone lost market share at a slower pace than expected.
The small-cap drugmaker's stock pared gains after Washington's move to kill the drug rebate rule, and ended 7% higher.
The pound firmed after the Fed's indications of an interest rate cut weakened the dollar and helped the mid-cap index outperform the main bourse.
Diploma was the stand out mid-cap gainer after an earnings-accretive acquisition of fluid sealing products supplier Virginia Sealing Products.
The world's oldest tour operator, Thomas Cook, climbed more than 10% after peer and Jet2 owner Dart Group reported higher annual earnings as Britons booked more holidays. Dart shares were 4.5% higher. (Reporting by Muvija M and Shashwat Awasthi in Bengaluru Editing by Bernard Orr, Arun Koyyur and Frances Kerry)